FDA Inspection 786813 — Siegfried Hameln GmbH

Siegfried Hameln GmbH — FEI 3002807877

The FDA completed an inspection of Siegfried Hameln GmbH on June 14, 2012 in Hameln. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 14, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hameln (Germany)